Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sham Mailankody
Baseline Mutational Patterns and Sustained MRD Negativity in Patients With High-Risk Smoldering Myeloma
Blood advances
Hematology
Stem Cell Mobilization and Autograft Purity With Novel Induction Regimens in Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
Four Genes Predict High Risk of Progression From Smoldering to Symptomatic Multiple Myeloma (SWOG S0120)
Haematologica
Hematology
Treatment Patterns and Outcomes in Elderly Patients With Multiple Myeloma,
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Hematology/Oncology Clinics of North America
Oncology
Hematology
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
A Multiepitope of XBP1, CD138 and CS1 Peptides Induces Myeloma-Specific Cytotoxic T Lymphocytes in T Cells of Smoldering Myeloma Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Smoldering Multiple Myeloma: Prevalence and Current Evidence Guiding Treatment Decisions
Blood and Lymphatic Cancer: Targets and Therapy
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
